CLINICAL_TRIALS trial_result · 2019-05-08

Clinical Trial Update: P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) [Phase 2]

Phase 2 dose-finding CNS MRI trial completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Guerbet | Conditions: CNS Lesion, Blood Brain Barrier Defect | Phase 2 | Status: COMPLETED | Results posted: 2019-05-08